Literature DB >> 17449516

Glioblastoma in a boy with fragile X: an unusual case of neuroprotection.

R Kalkunte1, D Macarthur, R Morton.   

Abstract

Glioblastomas in children usually occur in the brainstem and are often untreatable and associated with an extremely poor prognosis. Such tumours may however occur in supratentorial locations more typically associated with adult gliomas, where the outcome is more variable, but still poor. We report the case of a boy with fragile X who also developed an inoperable midbrain glioblastoma, but who has survived 8 years after diagnosis.

Entities:  

Mesh:

Year:  2007        PMID: 17449516      PMCID: PMC2084029          DOI: 10.1136/adc.2006.103382

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  3 in total

1.  Astrocytoma in children: 14 years' experience at Stanford University Medical Center.

Authors:  S Y Woo; S S Donaldson; R S Cox
Journal:  J Clin Oncol       Date:  1988-06       Impact factor: 44.544

2.  Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945.

Authors:  J H Wisoff; J M Boyett; M S Berger; C Brant; H Li; A J Yates; P McGuire-Cullen; P A Turski; L N Sutton; J C Allen; R J Packer; J L Finlay
Journal:  J Neurosurg       Date:  1998-07       Impact factor: 5.115

3.  Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost.

Authors:  P K Sneed; M D Prados; M W McDermott; D A Larson; M K Malec; K R Lamborn; R L Davis; K A Weaver; W M Wara; T L Phillips
Journal:  Neurosurgery       Date:  1995-05       Impact factor: 4.654

  3 in total
  11 in total

Review 1.  Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer.

Authors:  Mrinmoyee Majumder; Roger H Johnson; Viswanathan Palanisamy
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-09-02       Impact factor: 8.250

2.  Aging in Fragile X Premutation Carriers.

Authors:  Reymundo Lozano; Naomi Saito; Dallas Reed; Marwa Eldeeb; Andrea Schneider; David Hessl; Flora Tassone; Laurel Beckett; Randi Hagerman
Journal:  Cerebellum       Date:  2016-10       Impact factor: 3.847

3.  A feed-forward mechanism involving Drosophila fragile X mental retardation protein triggers a replication stress-induced DNA damage response.

Authors:  Wenxin Zhang; Ying Cheng; Yujing Li; Zhenping Chen; Peng Jin; Dahua Chen
Journal:  Hum Mol Genet       Date:  2014-05-15       Impact factor: 6.150

4.  Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge.

Authors:  Simone Carotti; Maria Zingariello; Maria Francesconi; Laura D'Andrea; M Ujue Latasa; Leticia Colyn; Maite G Fernandez-Barrena; Rocco Simone Flammia; Mario Falchi; Daniela Righi; Giorgia Pedini; Francesco Pantano; Claudia Bagni; Giuseppe Perrone; Rosa Alba Rana; Matias A Avila; Sergio Morini; Francesca Zalfa
Journal:  Oncogene       Date:  2021-05-20       Impact factor: 9.867

5.  The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells.

Authors:  Francesca Zalfa; Vincenzo Panasiti; Simone Carotti; Maria Zingariello; Giuseppe Perrone; Laura Sancillo; Laura Pacini; Flavie Luciani; Vincenzo Roberti; Silvia D'Amico; Rosa Coppola; Simona Osella Abate; Rosa Alba Rana; Anastasia De Luca; Mark Fiers; Valentina Melocchi; Fabrizio Bianchi; Maria Giulia Farace; Tilmann Achsel; Jean-Christophe Marine; Sergio Morini; Claudia Bagni
Journal:  Cell Death Dis       Date:  2017-11-16       Impact factor: 8.469

6.  Common Clinical Characteristics and Rare Medical Problems of Fragile X Syndrome in Thai Patients and Review of the Literature.

Authors:  Chariyawan Charalsawadi; Juthamas Wirojanan; Somchit Jaruratanasirikul; Nichara Ruangdaraganon; Alan Geater; Pornprot Limprasert
Journal:  Int J Pediatr       Date:  2017-06-29

7.  A cell-based fascin bioassay identifies compounds with potential anti-metastasis or cognition-enhancing functions.

Authors:  Robert Kraft; Allon Kahn; José L Medina-Franco; Mikayla L Orlowski; Cayla Baynes; Fabian López-Vallejo; Kobus Barnard; Gerald M Maggiora; Linda L Restifo
Journal:  Dis Model Mech       Date:  2012-08-23       Impact factor: 5.758

8.  The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation.

Authors:  Rossella Lucá; Michele Averna; Francesca Zalfa; Manuela Vecchi; Fabrizio Bianchi; Giorgio La Fata; Franca Del Nonno; Roberta Nardacci; Marco Bianchi; Paolo Nuciforo; Sebastian Munck; Paola Parrella; Rute Moura; Emanuela Signori; Robert Alston; Anna Kuchnio; Maria Giulia Farace; Vito Michele Fazio; Mauro Piacentini; Bart De Strooper; Tilmann Achsel; Giovanni Neri; Patrick Neven; D Gareth Evans; Peter Carmeliet; Massimiliano Mazzone; Claudia Bagni
Journal:  EMBO Mol Med       Date:  2013-09-16       Impact factor: 12.137

Review 9.  Transcriptional Reactivation of the FMR1 Gene. A Possible Approach to the Treatment of the Fragile X Syndrome.

Authors:  Elisabetta Tabolacci; Federica Palumbo; Veronica Nobile; Giovanni Neri
Journal:  Genes (Basel)       Date:  2016-08-17       Impact factor: 4.096

10.  Fragile X mental retardation protein promotes astrocytoma proliferation via the MEK/ERK signaling pathway.

Authors:  Zhou Xing; Minling Zeng; Huixian Hu; Hui Zhang; Zhuofang Hao; Yuesheng Long; Shengqiang Chen; Hang Su; Zhongmin Yuan; Meng Xu; Jingqi Chen
Journal:  Oncotarget       Date:  2016-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.